BSECompany Update▲ PositiveExpansion2h ago
Rubicon Research Ltd
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), 2015 (''SEBI Listing Regulations'') - Acquisition of a Manufacturing Facility in USA.
Rubicon Research Ltd, a pharmaceutical company, has acquired a manufacturing facility in East Brunswick, New Jersey, USA from InvaTech Pharma Solutions, LLC for an enterprise value of USD 2.9 million. The facility will focus on Rubicon's specialty and high-value products as well as demand from US government departments. Manufacturing is expected to commence in calendar year 2027.
Read more →📎 1 attachment